PURPOSE: To identify the underlying mutation and describe the phenotype in a consanguineous Kurdish family with Leber's congenital amaurosis (LCA)/early onset severe retinal dystrophy (EOSRD). METHODS: Members of the index family were followed up to 22 years by ophthalmological examinations, including best corrected visual acuity (BCVA), Goldmann visual field (GVF), two-color-threshold perimetry (2CTP) and Ganzfeld electroretinogram (ERG), fundus photographs, fundus autofluorescence (FAF), and optical coherence tomography (OCT). After excluding seven of nine known LCA/EOSRD genes in the index patient, linkage analysis was performed in the family using a microarray followed by microsatellite fine mapping and direct sequencing of candidate genes. RD3 was screened by direct sequencing of 85 independent patients with LCA/EOSRD presenting with a BCVA ≥ 1.0 LogMAR before the age of 2 years to assess the prevalence of RD3 mutations in LCA/EOSRD. Since RD3 and RetGC1 have a functional relation, study authors screened for a modifying effect of RD3 mutations in 17 independent patients with mutations in GUCY2D. RESULTS: BCVA was severely reduced from the earliest examinations (as early as 3 months), never exceeding 1.3 LogMAR. The disease presented as cone-rod dystrophy with dystrophic changes in the macula and bone spicules in the periphery on progression. Linkage analysis narrowed the region of interest towards the LCA12 locus. Direct sequencing of RD3 revealed a homozygous nonsense mutation (c.180C > A) in all affected members tested. Screening of additional unrelated LCA/EOSRD patients revealed only polymorphisms in RD3. CONCLUSIONS: This is the second family reported so far with mutations in RD3. Mutations in RD3 are a very rare cause of LCA associated with an extremely severe form of retinal dystrophy.
PURPOSE: To identify the underlying mutation and describe the phenotype in a consanguineous Kurdish family with Leber's congenital amaurosis (LCA)/early onset severe retinal dystrophy (EOSRD). METHODS: Members of the index family were followed up to 22 years by ophthalmological examinations, including best corrected visual acuity (BCVA), Goldmann visual field (GVF), two-color-threshold perimetry (2CTP) and Ganzfeld electroretinogram (ERG), fundus photographs, fundus autofluorescence (FAF), and optical coherence tomography (OCT). After excluding seven of nine known LCA/EOSRD genes in the index patient, linkage analysis was performed in the family using a microarray followed by microsatellite fine mapping and direct sequencing of candidate genes. RD3 was screened by direct sequencing of 85 independent patients with LCA/EOSRD presenting with a BCVA ≥ 1.0 LogMAR before the age of 2 years to assess the prevalence of RD3 mutations in LCA/EOSRD. Since RD3 and RetGC1 have a functional relation, study authors screened for a modifying effect of RD3 mutations in 17 independent patients with mutations in GUCY2D. RESULTS:BCVA was severely reduced from the earliest examinations (as early as 3 months), never exceeding 1.3 LogMAR. The disease presented as cone-rod dystrophy with dystrophic changes in the macula and bone spicules in the periphery on progression. Linkage analysis narrowed the region of interest towards the LCA12 locus. Direct sequencing of RD3 revealed a homozygous nonsense mutation (c.180C > A) in all affected members tested. Screening of additional unrelated LCA/EOSRD patients revealed only polymorphisms in RD3. CONCLUSIONS: This is the second family reported so far with mutations in RD3. Mutations in RD3 are a very rare cause of LCA associated with an extremely severe form of retinal dystrophy.
Authors: T P Dryja; S M Adams; J L Grimsby; T L McGee; D H Hong; T Li; S Andréasson; E L Berson Journal: Am J Hum Genet Date: 2001-03-29 Impact factor: 11.025
Authors: M M Sohocki; S J Bowne; L S Sullivan; S Blackshaw; C L Cepko; A M Payne; S S Bhattacharya; S Khaliq; S Qasim Mehdi; D G Birch; W R Harrison; F F Elder; J R Heckenlively; S P Daiger Journal: Nat Genet Date: 2000-01 Impact factor: 38.330
Authors: Xia Wang; Hui Wang; Ming Cao; Zhe Li; Xianfeng Chen; Claire Patenia; Athurva Gore; Emad B Abboud; Ali A Al-Rajhi; Richard A Lewis; James R Lupski; Graeme Mardon; Kun Zhang; Donna Muzny; Richard A Gibbs; Rui Chen Journal: Hum Mutat Date: 2011-09-23 Impact factor: 4.878
Authors: Andreas R Janecke; Debra A Thompson; Gerd Utermann; Christian Becker; Christian A Hübner; Eduard Schmid; Christina L McHenry; Anita R Nair; Franz Rüschendorf; John Heckenlively; Bernd Wissinger; Peter Nürnberg; Andreas Gal Journal: Nat Genet Date: 2004-07-18 Impact factor: 38.330
Authors: Birgit Lorenz; Bettina Wabbels; Erika Wegscheider; Christian P Hamel; Wolfgang Drexler; Markus N Preising Journal: Ophthalmology Date: 2004-08 Impact factor: 12.079
Authors: Igor V Peshenko; Qinhong Yu; Sunghyuk Lim; Diana Cudia; Alexander M Dizhoor; James B Ames Journal: J Biol Chem Date: 2018-12-17 Impact factor: 5.157
Authors: Laurie L Molday; Hidayat Djajadi; Paul Yan; Lukasz Szczygiel; Sanford L Boye; Vince A Chiodo; Kevin Gregory-Evans; Marinko V Sarunic; William W Hauswirth; Robert S Molday Journal: Hum Mol Genet Date: 2013-06-04 Impact factor: 6.150